Guideline-directed use of high-intensity statin therapy (HIST) significantly increased over the past 10 years and coincided with decreased population low-density lipoprotein cholesterol (LDL-C) levels among adults with atherosclerotic cardiovascular disease (ASCVD) enrolled in clinical pharmacy cardiac risk reduction service. The cross-sectional studies were performed over time, comprised of 18,006 adults with both acute and chronic ASCVD, to assess trends in statin use and LDL-C levels from 2007 to 2016. Researchers found:

The use of statin therapy (any intensity) remained relatively consistent throughout the study period.

The proportion of patients receiving HIST increased to a peak of 67%.

Use of prescription non-statin lipid-lowering therapy decreased from 25% to 2%.

The proportion of patients achieving LDL-C <70 mg/dL increased from 39% to 54%.